BFAM Partners Cayman Ltd's Q1 2020 13F is in

Form 13F-HR for the quarter ended Mar 31, 2020 · filed May 12, 2020 · 4 reported positions · accession 0001639101-20-000008 · Amended

View the filing on SEC.gov
Unusual change in filer or structure — comparison may be unreliable. Most of this quarter's reported value sits in positions that do not appear in the fund's prior filing, the number of reported positions collapsed against it, or it could not be fully matched. That usually means the fund changed how or under which entity it reports, not that it traded. Read the changes below with that in mind.

What changed this quarter

Changes are not listed for this filing: compared with the fund's prior filing they would mostly reflect the change in filer or structure, not trading. The positions the fund reported this quarter:

# Security Weight
1 CHINA BIOLOGIC PRODS HLDGS I (CBPO) 33.5%
2 SPDR GOLD TRUST (GLD) 33.5%
3 JD COM INC (JD) 30.7%
4 UNITED MICROELECTRONICS CORP (UMC) 2.4%

Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled

Top 10 positions — 100.0% of the equity book

# Security Weight now
1 CHINA BIOLOGIC PRODS HLDGS I (CBPO) 33.5%
2 SPDR GOLD TRUST (GLD) 33.5%
3 JD COM INC (JD) 30.7%
4 UNITED MICROELECTRONICS CORP (UMC) 2.4%

Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).